Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/123456789/4536
Full metadata record
DC FieldValueLanguage
dc.creatorMore B-
dc.creatorBhatt H-
dc.creatorKukreja V-
dc.creatorAinapure S-
dc.date2003-
dc.date.accessioned2013-05-30T11:21:14Z-
dc.date.available2013-05-30T11:21:14Z-
dc.date.issued2013-05-30-
dc.identifierhttp://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=1;spage=101;epage=3;aulast=More-
dc.identifierhttp://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=1&spage=101-
dc.identifier.urihttp://koha.mediu.edu.my:8181/jspui/handle/123456789/4536-
dc.publisherMedknow Publications-
dc.sourceJournal of Postgraduate Medicine-
dc.subjectAntiprotozoal Agents-
dc.subjectpharmacology-
dc.subjecttherapeutic use-
dc.subjectHuman-
dc.subjectLeishmaniasis-
dc.subjectVisceral-
dc.subjectdrug therapy-
dc.subjectPhosphorylcholine-
dc.subjectanalogs & derivatives-
dc.subjectpharmacology-
dc.subjecttherapeutic use-
dc.titleMiltefosine: great expectations against visceral leishmaniasis.-
Appears in Collections:Health Sciences

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.